ENETS standardized (synoptic) reporting for molecular imaging studies in neuroendocrine tumours

Rodney J. Hicks; Clarisse Dromain; Wouter W. de Herder; Frederico P. Costa; Christophe M. Deroose; Andrea Frilling; Anna Koumarianou; Eric P. Krenning; Eric Raymond; Lisa Bodei; Halfdan Sorbye; Staffan Welin; Bertram Wiedenmann; Damian Wild; James R. Howe; James Yao; Dermot O’Toole; Anders Sundin; Vikas Prasad

doi:10.1111/jne.13040

ENETS standardized (synoptic) reporting for molecular imaging studies in neuroendocrine tumours

Rodney J. Hicks, Clarisse Dromain, Wouter W. de Herder, Frederico P. Costa, Christophe M. Deroose, Andrea Frilling, Anna Koumarianou, Eric P. Krenning, Eric Raymond, Lisa Bodei, Halfdan Sorbye, Staffan Welin, Bertram Wiedenmann, Damian Wild, James R. Howe, James Yao, Dermot O’Toole, Anders Sundin, Vikas Prasad

Research output: Contribution to journal › Article › peer-review

15 Scopus citations

Abstract

The European Neuroendocrine Tumor Society (ENETS) promotes practices and procedures that aim to improve the standard of care delivered to patients diagnosed with or suspected of having neuroendocrine neoplasia (NEN). At its annual Scientific Advisory Board Meeting in 2018, experts in imaging, pathology and clinical care of patients with NEN drafted guidance for the standardised reporting of diagnostic studies critical to the diagnosis, grading, staging and treatment of NEN. These included pathology, radiology, endoscopy and molecular imaging procedures. In an iterative process, a synoptic reporting template for molecular imaging procedures was developed to guide personalised therapies. Following pilot implementation and refinement within the ENETS Center of Excellence network, harmonisation with specialist imaging societies including the Society of Nuclear Medicine, European Association of Nuclear Medicine and the International Cancer Imaging Society will be pursued.

Original language	English
Article number	e13040
Journal	Journal of Neuroendocrinology
Volume	34
Issue number	3
DOIs	https://doi.org/10.1111/jne.13040
State	Published - Mar 2022

Keywords

PET
neuroendocrine neoplasia
synoptic reporting

Access to Document

10.1111/jne.13040

Cite this

Hicks, R. J., Dromain, C., de Herder, W. W., Costa, F. P., Deroose, C. M., Frilling, A., Koumarianou, A., Krenning, E. P., Raymond, E., Bodei, L., Sorbye, H., Welin, S., Wiedenmann, B., Wild, D., Howe, J. R., Yao, J., O’Toole, D., Sundin, A., & Prasad, V. (2022). ENETS standardized (synoptic) reporting for molecular imaging studies in neuroendocrine tumours. Journal of Neuroendocrinology, 34(3), Article e13040. https://doi.org/10.1111/jne.13040

@article{d9ef657403b74057933f1e68075f4a85,

title = "ENETS standardized (synoptic) reporting for molecular imaging studies in neuroendocrine tumours",

abstract = "The European Neuroendocrine Tumor Society (ENETS) promotes practices and procedures that aim to improve the standard of care delivered to patients diagnosed with or suspected of having neuroendocrine neoplasia (NEN). At its annual Scientific Advisory Board Meeting in 2018, experts in imaging, pathology and clinical care of patients with NEN drafted guidance for the standardised reporting of diagnostic studies critical to the diagnosis, grading, staging and treatment of NEN. These included pathology, radiology, endoscopy and molecular imaging procedures. In an iterative process, a synoptic reporting template for molecular imaging procedures was developed to guide personalised therapies. Following pilot implementation and refinement within the ENETS Center of Excellence network, harmonisation with specialist imaging societies including the Society of Nuclear Medicine, European Association of Nuclear Medicine and the International Cancer Imaging Society will be pursued.",

keywords = "PET, neuroendocrine neoplasia, synoptic reporting",

author = "Hicks, {Rodney J.} and Clarisse Dromain and {de Herder}, {Wouter W.} and Costa, {Frederico P.} and Deroose, {Christophe M.} and Andrea Frilling and Anna Koumarianou and Krenning, {Eric P.} and Eric Raymond and Lisa Bodei and Halfdan Sorbye and Staffan Welin and Bertram Wiedenmann and Damian Wild and Howe, {James R.} and James Yao and Dermot O{\textquoteright}Toole and Anders Sundin and Vikas Prasad",

note = "Publisher Copyright: {\textcopyright} 2021 The Authors. Journal of Neuroendocrinology published by John Wiley & Sons Ltd on behalf of British Society for Neuroendocrinology.",

year = "2022",

month = mar,

doi = "10.1111/jne.13040",

language = "English",

volume = "34",

journal = "Journal of Neuroendocrinology",

issn = "0953-8194",

number = "3",

}

Hicks, RJ, Dromain, C, de Herder, WW, Costa, FP, Deroose, CM, Frilling, A, Koumarianou, A, Krenning, EP, Raymond, E, Bodei, L, Sorbye, H, Welin, S, Wiedenmann, B, Wild, D, Howe, JR, Yao, J, O’Toole, D, Sundin, A & Prasad, V 2022, 'ENETS standardized (synoptic) reporting for molecular imaging studies in neuroendocrine tumours', Journal of Neuroendocrinology, vol. 34, no. 3, e13040. https://doi.org/10.1111/jne.13040

TY - JOUR

T1 - ENETS standardized (synoptic) reporting for molecular imaging studies in neuroendocrine tumours

AU - Hicks, Rodney J.

AU - Dromain, Clarisse

AU - de Herder, Wouter W.

AU - Costa, Frederico P.

AU - Deroose, Christophe M.

AU - Frilling, Andrea

AU - Koumarianou, Anna

AU - Krenning, Eric P.

AU - Raymond, Eric

AU - Bodei, Lisa

AU - Sorbye, Halfdan

AU - Welin, Staffan

AU - Wiedenmann, Bertram

AU - Wild, Damian

AU - Howe, James R.

AU - Yao, James

AU - O’Toole, Dermot

AU - Sundin, Anders

AU - Prasad, Vikas

PY - 2022/3

Y1 - 2022/3

N2 - The European Neuroendocrine Tumor Society (ENETS) promotes practices and procedures that aim to improve the standard of care delivered to patients diagnosed with or suspected of having neuroendocrine neoplasia (NEN). At its annual Scientific Advisory Board Meeting in 2018, experts in imaging, pathology and clinical care of patients with NEN drafted guidance for the standardised reporting of diagnostic studies critical to the diagnosis, grading, staging and treatment of NEN. These included pathology, radiology, endoscopy and molecular imaging procedures. In an iterative process, a synoptic reporting template for molecular imaging procedures was developed to guide personalised therapies. Following pilot implementation and refinement within the ENETS Center of Excellence network, harmonisation with specialist imaging societies including the Society of Nuclear Medicine, European Association of Nuclear Medicine and the International Cancer Imaging Society will be pursued.

AB - The European Neuroendocrine Tumor Society (ENETS) promotes practices and procedures that aim to improve the standard of care delivered to patients diagnosed with or suspected of having neuroendocrine neoplasia (NEN). At its annual Scientific Advisory Board Meeting in 2018, experts in imaging, pathology and clinical care of patients with NEN drafted guidance for the standardised reporting of diagnostic studies critical to the diagnosis, grading, staging and treatment of NEN. These included pathology, radiology, endoscopy and molecular imaging procedures. In an iterative process, a synoptic reporting template for molecular imaging procedures was developed to guide personalised therapies. Following pilot implementation and refinement within the ENETS Center of Excellence network, harmonisation with specialist imaging societies including the Society of Nuclear Medicine, European Association of Nuclear Medicine and the International Cancer Imaging Society will be pursued.

KW - PET

KW - neuroendocrine neoplasia

KW - synoptic reporting

UR - http://www.scopus.com/inward/record.url?scp=85117273748&partnerID=8YFLogxK

U2 - 10.1111/jne.13040

DO - 10.1111/jne.13040

M3 - Article

C2 - 34668262

AN - SCOPUS:85117273748

SN - 0953-8194

VL - 34

JO - Journal of Neuroendocrinology

JF - Journal of Neuroendocrinology

IS - 3

M1 - e13040

ER -

ENETS standardized (synoptic) reporting for molecular imaging studies in neuroendocrine tumours

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this